Treatment of Parkinson's Flashcards

1
Q

types of abnormal movements

A
tremor
chorea
athetosis
dystonia 
tics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

tremor

A

rhythmic oscillations in joints

when at rest often assoc. w/ Parkinson’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

chorea

A

irregular jerkiness, esp at proximal muscles of limbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

athetosis

A

slow & writhing abnormal movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

dystonia

A

sustained (abnormal posture)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

tics

A

sudden, coordinated abnormal movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the effects of less DA in Parkinson’s disease?

A

less DA from Pars Compacta leads to more GLU from sub thalamic nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

About Parkinson’s disease

(What is it?) tell me about the disease

A

(movement disorder)

  • Tremors
  • Rigidity
  • Bradykinesia (slow movements) or akinesia (can’t initiate movement)
  • Posture Instability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does Parkinson’s disease cause?

A
  • degeneration of DA secreting neurons (sub migration PC)
  • Imbalance b/w DA & ACh
  • from toxin? (MPTP also knocks out same cells)
      • Maybe from MAO-B producing a toxin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What initiates the progression of Parkinson’s disease?

A
  • DA (from sub migration) activate receptors that inhibit GABA output (inhibit an inhibitory pathway)
  • ACh activates the same area that GABA inhibits. May be a imbalance b/w DA & ACh that’s important
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is MPTP?

A

Methyl phenyl tetra hydropyridine

  • a prodrug to the neurotoxin MPP+, which causes permanent symptoms of Parkinson’s disease
  • destroys dopaminergic neurons in the substantia migration in the brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MPTP hypothesis

A

manufacturing MPPP turned into MPTP, which allowed a patient to respond well to the Parkinson’s treatment.

he then died due to MPPP being a bad batch!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MPPP

A

Methyl phenyl proprionoxypiperidine
(DEA has labeled it as schedule I drug in the U.S.)

  • heroine like drug (meperidine-like)
  • quite addicting
  • gives euphoria & peaceful sense
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drugs that may induce PD

A
Serenace (haloperidol)
Stemetil (prochlorperazine)
Maxolon (metoclopramide)
Neulactil (pericyazine)
Risperidal (risperidone)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DA/ACh imbalance in Parkinson’s

A

dopamine deletion blocks auto inhibition of ACh through muscarinic autoreceptors which lead to excessive ACh release

(higher levels of ACh cause dyskinesia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

drugs used

A

Levodopa (MOST DRUG USED FOR THIS DISEASE)

  • dopamine won’t cross BBB
  • L-Dopa crosses BBB then gets converted to DA by dopa decarboxylase
    • “usually” reverses all effects of Parkinson’s
      * * but some do NOT respond
  • Up to 98% is converted to DA in periphery
    • causes GI distress & arrythmia
    • given with a peripheral dopa decarboxylase inhibitor
17
Q

Tyrosine/dopamine

A

enzymes in body convert tyrosine into dopamine

hense., tyrosine plays a critical role for the production of dopamine

18
Q

Side effects of Levodopa w/ Carbidopa

A
  1. Nausea/ vomiting
  2. CV
  3. Diskinesias
  4. Depression & Anxiety
  5. Loss of Efficacy
  6. End-of-Dose Phenomenon
19
Q

Nausea/ vomiting

A

(less frequent w/ decarboxylase inhibitor)

20
Q

CV

A

(arrhythmia & postural hypotension)

21
Q

Diskinesias

A

(in about 80% of patients)
(include dystopias, myoclonus, tics, tremors)
(usually after 3 months to 10 years on L-Dopa)

22
Q

Depression & Anxiety

A

(w/ elderly & w/ decarboxylase inhibitors)

23
Q

Loss of Efficacy

A

(due to tolerance)

due to progression of disease

24
Q

End-of-loss Phenomenon

A

(due to plasma concentrations)

use sustained release or change timing of drug administration

25
Q

Drug holidays

A

removing patient from L-Dopa for days/weeks so that can respond to the drug again

they may now need less of the drug for response

NOT EFFECTIVE IN ALL CASES

26
Q

Dopamine Agonists

A
  • Bromocryptine/ Pergolide (older, not used) OR
    Paramipexole (D3) OR Ropinirole (D2)
  • Used w/ L-Dopa for synergistic effect or for early treatment in patients that don’t tolerate L-Dopa well
27
Q

Side effects of Dopamine Agonists

A

GI–> Nausea/ vomiting
CV–> Postural hypotension
CNS–> Confusion, hallucinations

28
Q

Rasagiline & Selegiline

A

(MAO-B inhibitor)

- Used w/ levodopa

29
Q

Entacapone & Tolcapone

A

(COMT inhibitors)

30
Q

Benztropine

A

(antimuscarinic)
- Balance ACh effects that’s strong in Parkinson’s
(used w/ L-Dopa)
(can reduce tremor & rigidity)

31
Q

Amantidine

A

(anti-viral w/ unknown mechanism)
- used w/ L-Dopa or anti-cholinergics
(helps reduce symptoms w/ mild side effects)

32
Q

Treatment

A

May start w/ selegiline or amantidine, then L-Dopa

33
Q

Newest Treatments

A

Mirapex (pramipexole), Requip (ropinirole)

Tasmar (tolcapone), Comtan (entacapone)

34
Q

Mirapex (pramipexole), Requip (ropinirole)

A
  • Non-ergot DA agonists (type 2 autoreceptors)
  • Less DA release > less MAO free radicals > less Parkinson’s - like damage
  • Side effects:
    orthostatic hypotension, hallucinations, diskinesias, dry mouth
35
Q

Tasmar (tolcapone), Comtan (entacapone)

A

COMT inhibitors

  • Side effects:
    liver damage, sleep disturbances, hallucinations, dizziness/hypotension